Author: Ojosnegros, Samuel; Beerenwinkel, Niko
Title: Models of RNA virus evolution and their roles in vaccine design Document date: 2010_11_3
ID: 0q928h3b_34
Snippet: Recently, a combined vaccine of recombinant canarypox vector vaccine [99] plus a recombinant glycoprotein 120 subunit vaccine has been tested in phase III clinical trials in Thailand involving more than 16.000 subjects. The results showed a slight trend of protection in the vaccinated group when compared to the control group. Although these numbers are still debated [100] and vaccination did not affect the degree of viremia or CD4+ T cell count i.....
Document: Recently, a combined vaccine of recombinant canarypox vector vaccine [99] plus a recombinant glycoprotein 120 subunit vaccine has been tested in phase III clinical trials in Thailand involving more than 16.000 subjects. The results showed a slight trend of protection in the vaccinated group when compared to the control group. Although these numbers are still debated [100] and vaccination did not affect the degree of viremia or CD4+ T cell count in HIV infected subjects, the results offer insight for future research.
Search related documents:
Co phrase search for related documents- future research and subject involve: 1
- future research and subunit vaccine: 1
- future research and vector vaccine: 1
- recombinant glycoprotein and subunit vaccine: 1, 2, 3, 4, 5, 6
- recombinant glycoprotein and vector vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9
- subunit vaccine and vaccinated group: 1, 2, 3
- subunit vaccine and vector vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- vaccinated group and vector vaccine: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date